Coherus Biosciences | CHRS - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Fujifilm JPY 4.03T 548.71B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Merck USD 261.26B 51.62B 2025-12
Myriad Genetics USD 575M 98M 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12
Zoetis USD 55.45B 9.4B 2025-12